QIAGEN N.V. QGEN announced the launch of QIAcube Connect MDx platform for automated sample processing in molecular diagnostic laboratories. The platform will now be available in the United States and ...

Momentum building as QIAGEN prepares for three important new instrument launches in 2025 and 2026: QIAsymphony Connect, QIAsprint and QIAmini VENLO, Netherlands, & GERMANTOWN, Maryland, October 28, ...

QIAGEN announced the global launch of the QIAcube Connect MDx, a flexible platform for automated sample processing that will now be available to molecular diagnostic laboratories in the US and Canada, ...

The lab is the first of its kind between QIAGEN and a major research institution in China and is a key milestone in the Company's expansion in key emerging markets and as a leading player in ...

Momentum building as QIAGEN prepares for three important new instrument launches in 2025 and 2026: QIAsymphony Connect, QIAsprint and QIAmini QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today ...

QIAGEN N.V. QGEN announced the launch of QIAcube Connect MDx platform for automated sample processing in molecular diagnostic laboratories. The platform will now be available in the United States and ...

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the global launch of the QIAcube Connect MDx, a flexible platform for ...

VENLO, Netherlands, & GERMANTOWN, Maryland--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 4,000th placement of its QIAcube Connect instrument, a significant ...

QIAGEN N.V. QGEN announced the launch of QIAcube Connect MDx platform for automated sample processing in molecular diagnostic laboratories. The platform will now be available in the United States and ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 4,000th placement of its QIAcube Connect instrument, a significant milestone in driving automation adoption for sample processing ...